BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677 [PMID: 40656607 DOI: 10.3748/wjg.v31.i25.105677]
URL: https://www.wjgnet.com/2150-5349/full/v31/i25/105677.htm
Number Citing Articles
1
SirolimusReactions Weekly 2025; 2075(1) doi: 10.1007/s40278-025-89563-5
2
Junaid Khan, Daniel K Daniels. Thalidomide in gastrointestinal angiodysplasia: translating systematic evidence into clinical practiceJournal of Clinical and Experimental Gastroenterology 2026; 5(1) doi: 10.46439/gastro.5.032
3
Robert Sean O'Neill, Jeyvin Nandakumaran, Robert Feller. Sirolimus and gastrointestinal angiodysplasia: Can an established agent change the way gastrointestinal bleeding is managed?World Journal of Gastroenterology 2025; 31(41): 113736 doi: 10.3748/wjg.v31.i41.113736